With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...

A new study from Oregon Health & Science University has uncovered how small molecules within bacteria interact with proteins, ...

The AI in Drug Discovery Market is experiencing substantial expansion, boosted by AI-powered innovations in drug optimization, repurposing, and preclinical testing.Pune, Jan. 13, 2025 (GLOBE NEWSWIRE) ...

A study by this year's Nobel Laureate in Chemistry reveals a possible game-changer in snakebite treatment. Researchers have ...

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) today announced the launch of its AI-powered pipeline of both optimized and new ...

Insilico Medicine (“Insilico”), a clinical ... of artificial intelligence in the acceleration of target discovery and drug repurposing. AI has simplified target identification and improved ...

Enhanc3D Genomics (‘Enhanced’), an innovator in 3D genomics technology, today announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug ...

Verseon, a pioneering company in physics- and AI-powered drug discovery, revealed that its AI technology significantly ...

Insilico Medcine( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced the first patient has been dosed in the global multicenter Phase I ...